|
|
 |
Vivek Mehta, M.D. - complete profile
Radiation Oncologist Director, Center for Advanced Targeted Radiation Therapies
I am committed to winning the war against cancer. The team of researchers we have developed at the Swedish Cancer Institute is working to optimize the implementation of new technologies. Our goal is to improve care for our patients in Washington and to teach other physicians around the country about best utilizing newer techniques. We are beginning to treat patients more aggressively and with fewer side effects. It has been exciting to be part of the continual improvement in patient care.
Education & Certification
Medical School: University of Washington School of Medicine, Seattle, Wash. Internship: Legacy Good Samaritan Hospital & Medical Center, and Legacy Emanuel Hospital & Health Center, Portland, Ore.
Fellowship: Chief Resident - Stanford University Medical Center, Palo Alto, Calif.
Board Certification: Board certified in therapeutic radiology (American Board of Radiology)
Additional Certifications: CyberKnife (Accuray), GammaKnife
Clinical Interests
- GammaKnife Radiosurgery
- Clinical treatment planning: volumetric modulated arc therapy (VMAT), intensity modulated radiotherapy (IMRT), four-dimensional (4-D) treatment planning, three-dimensional (3-D) conformal treatment planning
- Radioimmunotherapy/targeted radiolabeled antibodies
- Electronic brachytherapy (Xoft Inc.)
- Intraoperative radiotherapy/brachytherapy
- Balloon breast brachytherapy
Professional Highlights
- Seattle's Top Doctors List, Seattle Magazine, 2004, 2006, 2007, 2008, 2009
- Seattle's Top Physicians, Seattle Metropolitan, 2007, 2008, 2009
- Swedish Cancer Institute, Radiation Safety Committee (Chairman, 2009)
- Director, Center for Advanced Targeted Radiation Therapy, Swedish Cancer Institute
- Member of the American Society of Therapeutic Radiation Oncologists, the American Association of Indian Physicians, the American Society of Clinical Oncology, the Washington State Radiation Oncology Society
Research & Selected Publications
Research & Clinical Trials
- Radiation Therapy Oncology Group, Swedish Cancer Institute (Principle Investigator)
- Image Guided Radiotherapy Research Program, Swedish Cancer Institute (principle investigator)
- Volumetric Arc Therapy Research Program, Swedish Cancer Institute (co-principle investigator)
- Xoft Electronic Brachytherapy System for Use in Patients with Early Stage Breast Cancer, national multi-center trial (lead principal investigator)
- Mammosite RTS as the Sole Radiation Modality for Patients with DCIS, Swedish Cancer Institute, multi-center trial. (principal investigator; participant accruing complete, now in follow-up period)
Book Chapters
Buduhan, G., and S. Meran, R. Aye, B. Louie, V.K. Mehta, E. Valleries, “Trimodality Therapy for Malignant Mesotheloma,“ (submitted for publication 2009).
Mehta, V.K., “Pancreatic Cancer,“ in Jiade J. Lu and Luther W. Brady (Editors), Medical Radiology - Radiation Oncology: An Evidence-Based Approach, 2008.
Mehta, V.K., and G.A. Fisher, “Carcinoma of the Ampulla of Vater,“ in M. Perry, F. Talavera, M. Kahn, S. Plantz, M. Zevitz (Editors), E-Medicine: Medicine, Surgery and Gynecology, 2000. (in press)
Mehta, V.K., and G.A. Fisher, “Gastric Cancer,“ in M. Perry, F. Talavera, M. Kahn, S. Plantz, M. Zevitz (Editors), EMedicine: Medicine, Surgery and Gynecology, 2000. (in press)
Mehta, V.K., and J. Palmer, “The Natural History of the IDDM Disease Process,“ J. Palmer (Editor), Prediction, Prevention and Genetic Counseling in IDDM, pp. 1-17, New York: John Wiley and Sons, 1996
Selected Publications
Buduhan, G., and S. Meran, R. Aye, B. Louie, V.K. Mehta, E. Valleries, “Trimodality Therapy for Malignant Mesothelioma,“ The Annals of Thoracic Surgery, 2009; 88:870-876
Mehta, V.K., and K. Dowlatshai, W. Dooley, E. Syzek, S. Ahmad, K.L. Griem, A.T. Dickler, K. Haile, D.E. Wazer, S. Kurtzman, M. Chadha, R.E. Steven, A. Lerner, S. Modin, K.W. Elliott, “Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation,“ (submitted for publication in American Journal of Clinical Oncology, 2009)
Fesinmeyer, M.D., and V. Mehta, D. Bough, L. Tock, C. McDermott, S. Ramsey, “Completion of Radiotherapy for Loacal and Regional Head and Neck Cancer in Medicare,“ The Archives of Otolaryngology - Head & Neck Surgery, 2009; Sep: 135(9):860-7
Fesinmeyer, M.D., and D. Bough, V. Mehta, L. Tock, C. McDermott, S. Ramsey, “Early Discontinuation of Radiation Therapy Treatment among Medicare Enrollees with Local and Regional Stage Head and Neck Cancer,“ (submitted for publication in International Journal of Radiation Oncology, Biology and Physics, 2009)
Benitez, P.R., and O. Streeter, F. Vicini, V. Mehta, C. Quiet, R. Kuske, M.K. Hayes, D. Arthur, H. Kuerer, G. Freedman, M. Keisch, T. Dipetrillo, D. Khan, R. Hudes, “Preliminary Results and Evaluation af Mammosite Balloon Brachytherapy for Partial Breast Irradiation for Pure Ductal Carcinoma In Situ: A Phase II Clinical Study,“ American Journal of Surgery, Vol. 192, No. 4, October 2006, pp. 427-33.
Mehta, V.K., and R. Wynn, “Reduction of Treatment Breaks and Radiation-Induced Esophagitis and Pneumonitis Using Amifostine Inunresectable Non-Small Cell Lung Cancer Patients Receiving Definitive Concurrent Chemotherapy and Radiation Therapy: A Prospective Community Based Clinical Trial,“ Seminars in Oncology, Vol. 32 (2 Suppl 3), April 2005, pp. S99-104.
Mehta, V.K., “Radiation Pneumonitis and Fibrosis,“ International Journal of Radiation Oncology, Biology, Physics, Vol. 63, No. 1, September 2005, pp. 5-24.
Su, C., and V. Mehta, L. Ravikumar, R. Shah, H. Pinto, J. Halpern, A. Koong, D. Goffinet, Q.T. Le, “Phase II Double-Blind Randomized Study Comparing Oral Aloe Vera Versus Placebo to Prevent Radiation-Related Mucositis in Patients with Head-And-Neck Neoplasms,“ International Journal of Radiation Oncology, Biology, Physics, Vol. 60, No. 1, September 2004, pp. 171-7.
Mehta, V.K., “Open Label Multi-center Trial of Subcutaneous Amifostine (Ethyol) in the Prevention of Radiation Induced Esophagitis and Pneumonitis in Patients with Measurable, Unresectable Non-Small Cell Lung Cancer,“ Seminars in Oncology. Vol. 31 (suppl 18), 2004; pp. 42-46.
Koong, A.C., and Q.T. Le, A. Ho, B. Fong, G. Fisher, C. Cho, J. Ford, J. Poen, I.C. Gibbs, V.K. Mehta, S. Kee, W. Trueblood, G. Yang, J.A. Bastidas, “Phase I Study of Stereotactic Radiosurgery in Patients with Locally Advanced Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics, Vol. 58, No. 4, 2004, pp. 1017-1021.
Mehta, V., “Open Label Multicenter Trial of Subcutaneous Amifostine (Ethyol) in the Prevention of Radiation Induced Esophagitis and Pneumonitis in Patients with Measurable, Unresectable Non-Small Cell Lung Cancer,“ Seminars in Oncology, Vol. 31 (suppl 18), December 2004, pp. 42-6.
Mehta, V.K., and D. Goffinet, “Post Mastectomy Radiation Therapy after TRAM Flap Breast Reconstruction,“ The Breast Journal, Vol. 10, No. 2, pp. 118-22.
Mehta, V.K., and J. Ford, A.J. Bastidas, C. Cho, C. Jambalos, J. Poen, A.C. Koong, A. Lin, H. Young, G.A. Fisher. A Phase II Trial of Preoperative 3D Conformal Radiotherapy, Protracted Venous Infusion 5-FU, Weekly CPT-11 Followed by Surgery for Ultrasound Staged T3 Rectal Cancer. International Journal of Radiation Oncology Biology Physics, Vol. 55, No. 1, 2003, pp. 132-137.
Mehta, V.K., and Q.T. Le, S.D. Chang, S. Chenery, J.R. Adler, “Fractionated Stereotactic Radiosurgery for Tumors Near the Optic Nerve,“ Technology in Cancer Research & Treatment, Vol. 1, No. 3, 2002, pp. 173-179.
Mehta, V.K., and J.C. Poen, J.M. Ford, H.A. Oberhelman, M.A. Vierra, A.J. Bastidas, G.A. Fisher. Protracted Venous Infusion 5-Fluorouracil with Concomitant Radiotherapy Compared to Bolus 5-Fluorouracil for Unresectable Pancreatic Cancer, American Journal of Clinical Oncology, Vol 24, No. 2, 2001, pp. 155-59.
Smitt, M.C., and Mehta, V.K., “Is Diagnostic Review of Radiotherapy-Planning CT Scans Important in the Conformal Therapy Era? “, American Journal of Roentgenol, Vol. 177, No. 3, 2001, pp. 521-4.
Gurung RAR, Mehta VK. Relating ethnic identity, acculturation, and attitudes toward treating minority clients. Cultural Diversity and Ethnic Minority Psychology, 2001; 7(2):139-151.
Mehta, V.K., and J.C. Poen, M.A. Vierra, H.A. Oberhelman, J.M. Ford, G.A. Fisher, J. Niederhuber, A.J. Bastidas, “Preoperative Chemo Radiotherapy for Marginally Resectable Pancreatic Cancer,“ Journal of Gastrointestinal Surgery, Vol. 5, No. 1, 2001, pp. 27-35.
Mehta, V.K., and D.R. Goffinet, “Unsuspected Abnormalities Noted on CT Treatment Planning Scans Obtained for Breast and Chest Wall Irradiation,“ International Journal of Radiation Oncology, Biology, Physics, Vol. 49, No. 3, 2001, pp. 723-5.
Mehta, V.K., and G. Fisher, J.M. Ford, J.C. Poen, M.A. Vierra, H.A. Oberhelman, A.J. Bastidas. “Adjuvant Chemoradiotherapy for 'Unfavorable' Carcinoma of the Ampulla of Vater: A Preliminary Report,“ Archives of Surgery, Vol. 136, 2001, pp. 65-69.
Mehta, V.K., and J. Poen, J. Ford, H. Young, A.J. Bastidas, M.A. Vierra, P. Edelstein, G.A. Fisher, “Radiotherapy, Concomitant Protracted Venous Infusion 5-Fluorouracil, and Surgery for Ultrasound Stage T3/T4 Rectal Cancer,“ Diseases of the Colon & Rectum, Vol. 44, 2001, pp. 52-58.
Mehta, V.K., and G.A. Fisher, J.M. Ford, H.A. Oberhelman, M.A. Vierra, A.J. Bastidas, J.C. Poen, “Adjuvant Radiotherapy and Concomitant 5-Fluorouracil By Protracted Venous Infusion for Resected Pancreatic Cancer,“ International Journal of Radiation Oncology, Biology, Physics, Vol. 48, 2000, pp. 1483-1487.
Koong, A.C., and Mehta, V.K., and Q.T. Le, G.A. Fisher, D.J. Terris, J.M. Brown, M. Vierra, A. J. Bastidas, “Pancreatic Tumors Show High Levels of Hypoxia,“ International Journal of Radiation Oncology, Biology, Physics, Vol. 48, 2000; pp. 919-922.
Mehta, V.K., and G. Blume, “Randomized Clinical Trial of Fluoxetine in a Patient with Persistent Fatigue,“ Journal of American Board of Family Practice, Vol. 8, 1995, pp. 230-232.
Mehta, V.K., and M.A.A. Namboodiri, “N-Acetylaspartate as an Acetyl Source in the Nervous System,“ Molecular Brain Research, Vol. 31, 1995, pp. 151-57.
Mehta, V.K., and W. Hao, B. Brooks-Worrell, J. Palmer, “Low Dose Interleukin-1 and Tumor Necrosis Factor Individually Stimulate Insulin Release but in Combination Cause Suppression,“ European Journal of Endocrinology, Vol. 130, 1994, pp. 208-14.
Hao, W., and L. Li L, V.K. Mehta, A. Lernmark, J. Palmer, “The Functional State of the Beta Cell Affects Expression of Both Forms of Glutamic Acid Decarboxylase,“ Pancreas, Vol. 9, 1994, pp. 558-562.
Mehta, V.K., and W. Hao, B. Brooks-Worrell, J. Palmer. “The Functional State of the Beta Cell Modulates Interleukin-1 and Tumor Necrosis Factor Induced Cytotoxicity,“ Lymphokine and Cytokine Research, Vol. 12, 1993, pp. 255-259.
Selected Presentations
Dr. Mehta's expertise is recognized worldwide. Each year he is an invited speaker at multiple gatherings of physicians and researchers in Washington, across the country and internationally.
Personal Interests
I enjoy playing basketball, running and working out. I'm an amateur chef and enjoy cooking a variety of cuisines. I'm also a huge sports fan.
|
 |
|